Medical devices, healthcare technology and the business of care
510(k) clearance · K261676

uPMR Zenith

Shanghai United Imaging Healthcare Co., Ltd. · Decision date Oct 28, 2026

MEDTECHLEDGER EXPLANATIONK261676

What did the FDA decide?

FDA recorded a substantially equivalent (SESE) decision for the uPMR Zenith, a tomographic imager combining emission computed tomography with nuclear magnetic resonance, under 510(k) number K261676. The applicant is Shanghai United Imaging Healthcare Co., Ltd. of Shanghai, China. The decision date is 2026-10-28, with the application received 05/21/2026. The submission is a Traditional 510(k) in the Radiology specialty and review panel, classified under product code OUO with subsequent product code MOS and regulation number 892.1200.

SESE in this 510(k) context means the device was cleared as substantially equivalent to a legally marketed predicate; it is not a PMA approval. The record shows the review was not conducted by a third party, the product was not a combination product, and no Predetermined Change Control Plan was authorized. The public record does not state the predicate device, the specific components or changes assessed, or any clinical performance data, so those details remain unknown from this source.

The listed device classification name describes a combined emission computed tomography and nuclear magnetic resonance imager, but the record does not specify the device's indications, patient-selection criteria, imaging protocols or labeling. Those elements would need to be read from the linked FDA summary document rather than inferred here.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Radiology
Decision date
Oct 28, 2026
FDA decision documents: 510(k) Premarket Notification

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
K261676
Regulatory pathway
510(k) premarket notification
Product code
OUO
Decision code
SESE
Decision date
Oct 28, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Tomographic Imager Combining Emission Computed Tomography With Nuclear Magnetic Resonance.

Product code
OUO
FDA device class
2

FDA decision timeline

  1. K261676 received

    Application receipt date recorded by FDA.

  2. K261676 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

No additional submissions with a verified PMA or product-code relationship are linked here.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Shanghai United Imaging Healthcare Co., Ltd.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Shanghai

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records